Clean Catch Urine Feasibility and Contamination Rate Compared to Bladder Catheterization Urine in Pre-Continent Children
Launched by OMAN MEDICAL SPECIALITY BOARD · Feb 14, 2024
Trial Information
Current as of August 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods for collecting urine samples from young infants who may have urinary tract infections (UTIs). The researchers want to see if a non-invasive method called "clean catch urine" (which involves gently massaging the bladder) is as effective and has a lower risk of contamination compared to the standard method of bladder catheterization, which is more invasive and can be uncomfortable for the baby. The trial will include infants aged 0 to 6 months who are stable and need a urine sample for diagnosis in the emergency department.
Participants in the trial will be randomly assigned to one of two groups: one group will have their urine collected using the clean catch method, while the other group will undergo bladder catheterization. During the process, the researchers will track how long each method takes, any pain experienced by the infants, and parents' satisfaction with the procedure. This study aims to provide valuable information that could improve how urine samples are collected from infants in the future, making it easier and more comfortable for both babies and their families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hemodynamically stable infants.
- • Require urine collection as part of their work-up in the emergency department.
- • Age 0 to 6 months.
- Exclusion Criteria:
- • Parental refusal.
- • Unstable hemodynamically young infants.
About Oman Medical Speciality Board
The Oman Medical Specialty Board (OMSB) is a leading regulatory and educational authority dedicated to advancing medical education and healthcare standards in Oman. Established to enhance the quality of medical training and practice, OMSB plays a pivotal role in overseeing clinical trials, ensuring they adhere to rigorous ethical and scientific standards. By fostering collaboration between healthcare professionals, researchers, and institutions, OMSB aims to promote evidence-based medicine and drive innovation in clinical practices, ultimately improving patient outcomes and healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Lubna M Al Lawati, MD
Study Director
Oman Medical Speciality Board
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported